1 / 11

Oesteoporosis Drugs Market PDF, Size, Share, Trends, Industry Scope 2021-2026

According to the latest report by IMARC Group,the global osteoporosis drugs market size grew at a CAGR of around 5% during 2015-2020. <br>Osteoporosis refers to a medical condition that weakens the bone tissues, rendering them brittle and prone to sudden and unexpected fractures.

imarcgroups
Download Presentation

Oesteoporosis Drugs Market PDF, Size, Share, Trends, Industry Scope 2021-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Osteoporosis Drugs Market Research Report and Forecast 2021-2026 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

  2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

  3. Report Description and Highlights Report Description Global Osteoporosis Drugs Market Outlook 2026: According to the latest report by IMARC Group, titled "Osteoporosis Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global osteoporosis drugs market size grew at a CAGR of around 5% during 2015-2020. Osteoporosis refers to a medical condition that weakens the bone tissues, rendering them brittle and prone to sudden and unexpected fractures. Characterized by lower bone mass, it can cause deterioration of strength in the hip, spine or wrist. It can be diagnosed with the help of X-ray scans, computed tomography (CT) and magnetic resonance imaging (MRI). Upon detection, various drugs are prescribed to the patient that assist in repairing microscopic defects in bones and minimizing the risk of fractures. These medicines can also be used to restore the balance of resorption and formation, thereby enhancing the overall muscle strength in patients.

  4. Report Description and Highlights Report Description Global Osteoporosis Drugs Market Trends: The global market is majorly driven by the rising prevalence of osteoporosis among the masses. This can be accredited to the increasing consumption of tobacco and alcohol and the lack of physical activities among individuals. The increasing incidences of rheumatoid arthritis and menopause among the female population act as a contributing factor to the escalating number of cases of osteoporosis across the globe. Moreover, there has been a considerable rise in the geriatric population that is more susceptible to developing bone-related disorders, which is creating a positive outlook for the market. This is also supported by the growing awareness among the masses regarding the availability of cost- efficient treatment plans across the healthcare sector. Request for a free sample report: https://www.imarcgroup.com/osteoporosis-drugs- market/requestsample

  5. Report Description Report Description and Highlights Furthermore, extensive research and development (R&D) activities conducted by players have led to the development of drugs that offer enhanced efficacy. There has also been a rise in the number of pipeline drugs in clinical trials with a high probability of approval in the near future. Coupled with the increasing healthcare expenditure, this is anticipated to create a positive outlook for the market. Market Summary: Breakup by Product type: • Bisphosphonates • Calcitonin • Rank ligand inhibitor • Parathyroid hormone therapy • Selective estrogen receptor modulators • Sclerostin inhibitor

  6. Report Description Report Description and Highlights Breakup by Route: • Oral • Injectable Breakup by Region: • North America • Europe • Asia Pacific • Latin America • Middle East and Africa On account of the aforementioned factors, the market is expected to witness moderate growth during 2021-2026.

  7. Report Description and Highlights Report Description Competitive Landscape With Keyplayer: • Amgen Inc. • Eli Lilly and Company • F. Hoffmann-La Roche AG • GlaxoSmithKline Plc, Merck & Co. Inc. • Novartis AG, Pfizer Inc. • Radius Health Inc. • Teva Pharmaceutical Industries Ltd. • UCB S.A. View Report TOC, Figures and Tables : https://www.imarcgroup.com/osteoporosis-drugs-market

  8. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

  9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

  10. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

  11. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com

More Related